Group 1 - The core viewpoint of the news is that Dongxing Medical has experienced a decline in stock performance and financial metrics, indicating potential challenges in its business operations [1][2]. - On December 31, Dongxing Medical's stock fell by 0.94%, with a trading volume of 12.79 million yuan. The net financing buy was -204.70 thousand yuan, indicating more selling than buying in the financing market [1]. - As of December 31, the total balance of margin trading for Dongxing Medical was 79.95 million yuan, with a financing balance of 79.65 million yuan, accounting for 4.59% of the circulating market value, which is above the 50% percentile level over the past year [1]. Group 2 - As of December 19, the number of shareholders for Dongxing Medical was 9,304, a decrease of 2.90% from the previous period, while the average circulating shares per person increased by 2.99% to 7,325 shares [2]. - For the period from January to September 2025, Dongxing Medical reported a revenue of 284 million yuan, a year-on-year decrease of 10.21%, and a net profit attributable to shareholders of -53.20 million yuan, reflecting a significant decline of 181.13% [2]. - Since its A-share listing, Dongxing Medical has distributed a total of 169 million yuan in dividends [3].
东星医疗12月31日获融资买入62.23万元，融资余额7965.29万元